Table 1 Clinical characteristics and demographic data of the main screening urothelial bladder cancer cohort were used in this study. Within the Recurrences group, “Few” is defined as less than three recurrent tumours within 18 months, whereas “Frequent” is defined as three or more recurrences within the same period [18]
Plasma n = 90 | Urine n = 33 | |
|---|---|---|
Sex | ||
Female | 23 (26%) | 11 (33%) |
Male | 67 (74%) | 22 (67%) |
Age | 72 (64, 77) | 72 (64, 78) |
Stage Grade | ||
Ta Low grade | 21 (23%) | 7 (21%) |
Ta High grade | 10 (11%) | 3 (9%) |
T1 Low grade | 3 (3%) | 1 (3%) |
T1 High grade | 27 (30%) | 10 (30%) |
T2, T3, T4 High grade | 29 (32%) | 12 (36%) |
Invasiveness status | ||
NMIBC | 61 (68%) | 21 (64%) |
MIBC | 29 (32%) | 12 (36%) |
Recurrences | ||
No | 26 (29%) | 11 (33%) |
Few | 37 (41%) | 10 (30%) |
Frequent | 16 (18%) | 6 (18%) |
Unknown | 11 (12%) | 6 (18%) |
Progressed to MIBC | ||
No | 65 (72%) | 24 (73%) |
Yes | 18 (20%) | 7 (21%) |
Unknown | 7 (8%) | 2 (6%) |